ClinicalTrials.Veeva

Menu

Assessing Ventilator Safety in Patients on Pressure-Support Ventilation (ASOP)

Duke University logo

Duke University

Status

Completed

Conditions

Mechanical Ventilation Complication
Ventilator-Induced Lung Injury
Acute Respiratory Failure

Treatments

Device: Viasys Avea Ventilator
Device: Servo U ventilator
Device: Philips Respironics NM3 device
Device: Vyaire SmartCath adult nasogastric tube with Esophageal balloon

Study type

Interventional

Funder types

Other

Identifiers

NCT05125952
Pro00106860

Details and patient eligibility

About

ASOP is a prospective cohort study comparing three methods for assessing risk of self-induced lung injury in patients with acute respiratory failure being managed with pressure-support ventilation. We will describe the relationship between three different assessment methods for risk of self-induced lung injury and compare them to a gold standard measurement.

Full description

Ventilator-induced lung injury (VILI) is known to cause significant morbidity and mortality in patients with acute respiratory failure. Most studies on VILI have involved the effects of inappropriate (often excessive) mechanical ventilator settings. More recently, it has been noted that similar lung damage can be caused by large, patient generated, uncontrolled tidal volumes and driving pressures, which has been termed "self-induced lung injury," or SILI.

Pressure-support ventilation (PSV) is a common mechanical ventilation mode often used in patients with active inspiratory efforts to help reduce patient inspiratory work and improve comfort. PSV effectively allows spontaneously breathing patients to determine their breath flow-rate and breath duration, eliminating flow and cycle dyssynchrony. However, pressure support ventilation does not allow for physicians to control tidal volume or driving pressure. The risk of SILI may thus be increased with PSV.

Several different methods have been proposed to address these challenges. However, to date none of these methods have been compared to assess for concordance in their ability to indicate an increased risk of self-induced lung injury. ASOP is a prospective cohort study comparing three methods for assessing risk of self-induced lung injury in patients with acute respiratory failure being managed with pressure-support ventilation.

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients age ≥18 years with acute respiratory failure receiving invasive mechanical ventilation
  • Managed in pressure-support mode of ventilation

Exclusion criteria

  • Actively undergoing a spontaneously awakening trial or SAT
  • Patient or surrogate is unable to provide informed consent
  • Currently pregnant
  • Currently incarcerated
  • Acute exacerbation of an obstructive lung disease
  • Known esophageal varices or any other condition for which the attending physician deems an orogastric catheter to be unsafe
  • Esophageal, gastric or duodenal surgical procedures within the last 6 months

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Acute Respiratory Failure
Experimental group
Description:
Patients with acute respiratory failure managed with pressure-support ventilation.
Treatment:
Device: Servo U ventilator
Device: Philips Respironics NM3 device
Device: Viasys Avea Ventilator
Device: Vyaire SmartCath adult nasogastric tube with Esophageal balloon

Trial contacts and locations

1

Loading...

Central trial contact

Elias H Pratt, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems